日本語English简体中文 繁體中文

600332 Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited白云山Shanghai Stock Exchange

0 posts

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (600332) at a glance

Code
600332
Company
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
Local name
白云山
Market
Shanghai Stock Exchange
Share price
CN¥19.22 -0.19 (-0.98%) Nov 20 close

Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (600332) Stock Price HistoryNear a 52-week low

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited closed at CN¥19.22 on Nov 20, 2026, −3.1% over 1 month, −26.9% over 1 year.

2026-10-27 新薬・製品の承認 广州白云山医药集团股份有限公司关于子公司药物进入II期临床试验的…2026-10-29 取締役会決議 广州白云山医药集团股份有限公司第十届董事会第五次会议决议公告 / 新薬・製品の承認 广州白云山医药集团股份有限公司关于子公司收到澳门中成药注册证明… / 第3四半期報告 广州白云山医药集团股份有限公司2026年第三季度报告2026-10-30 新薬・製品の承認 广州白云山医药集团股份有限公司关于分公司收到药品注册证书的公告2026-11-10 取締役会決議 广州白云山医药集团股份有限公司第十届董事会第六次会议决议公告2026-11-16 株主総会の招集 广州白云山医药集团股份有限公司关于召开2026年第二次临时股东会的通…2026-11-19 株主総会 广州白云山医药集团股份有限公司2026年第二次临时股东会会议资料CN¥20.25CN¥19.22Oct 20Nov 20
Price5-day MA25-day MASSE CompositeDisclosures
1-Month HighCN¥20.25Nov 3
1-Month LowCN¥19.22Nov 20
1-Week Change−0.7%vs Nov 13
1-Month Change−3.1%vs Oct 20

If you had invested CN¥10,000 1 month ago, it would be worth CN¥9,688 today (−3.1%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved −5.4%, while this stock moved −3.1%.

Last 10 Trading Days

DateCloseChange% Change
Nov 20 (Fri)CN¥19.22−0.19−0.98%
Nov 19 (Thu)CN¥19.41−0.05−0.26%
Nov 18 (Wed)CN¥19.46−0.22−1.12%
Nov 17 (Tue)CN¥19.68+0.09+0.46%
Nov 16 (Mon)CN¥19.59+0.24+1.24%
Nov 13 (Fri)CN¥19.35−0.12−0.62%
Nov 12 (Thu)CN¥19.47−0.04−0.21%
Nov 11 (Wed)CN¥19.51−0.21−1.06%
Nov 10 (Tue)CN¥19.72−0.19−0.95%
Nov 9 (Mon)CN¥19.91−0.18−0.90%
2026-09-22 変更届 广州白云山医药集团股份有限公司关于控股股东股权结构变更的提示性公告2026-10-10 対外投資 广州白云山医药集团股份有限公司关于股权投资基金完成管理人变更备案暨关联… / 新薬・製品の承認 广州白云山医药集团股份有限公司关于子公司收到药品注册证书的公告2026-10-13 新薬・製品の承認 广州白云山医药集团股份有限公司关于子公司获得药物临床试验批准通…2026-10-14 取締役会 H股公告(董事会召开日期)2026-10-16 新薬・製品の承認 广州白云山医药集团股份有限公司关于子公司药品通过仿制药一致性评…2026-10-27 新薬・製品の承認 广州白云山医药集团股份有限公司关于子公司药物进入II期临床试验的…2026-10-29 取締役会決議 广州白云山医药集团股份有限公司第十届董事会第五次会议决议公告 / 新薬・製品の承認 广州白云山医药集团股份有限公司关于子公司收到澳门中成药注册证明… / 第3四半期報告 广州白云山医药集团股份有限公司2026年第三季度报告2026-10-30 新薬・製品の承認 广州白云山医药集团股份有限公司关于分公司收到药品注册证书的公告2026-11-10 取締役会決議 广州白云山医药集团股份有限公司第十届董事会第六次会议决议公告2026-11-16 株主総会の招集 广州白云山医药集团股份有限公司关于召开2026年第二次临时股东会的通…2026-11-19 株主総会 广州白云山医药集团股份有限公司2026年第二次临时股东会会议资料CN¥21.51CN¥19.22Aug 20Nov 20
Price5-day MA25-day MASSE CompositeDisclosures
3-Month HighCN¥21.51Aug 20
3-Month LowCN¥19.22Nov 20
1-Month Change−3.1%vs Oct 20
3-Month Change−10.6%vs Aug 20

If you had invested CN¥10,000 3 months ago, it would be worth CN¥8,935 today (−10.6%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved −9.5%, while this stock moved −10.6%.

Last 10 Trading Days

DateCloseChange% Change
Nov 20 (Fri)CN¥19.22−0.19−0.98%
Nov 19 (Thu)CN¥19.41−0.05−0.26%
Nov 18 (Wed)CN¥19.46−0.22−1.12%
Nov 17 (Tue)CN¥19.68+0.09+0.46%
Nov 16 (Mon)CN¥19.59+0.24+1.24%
Nov 13 (Fri)CN¥19.35−0.12−0.62%
Nov 12 (Thu)CN¥19.47−0.04−0.21%
Nov 11 (Wed)CN¥19.51−0.21−1.06%
Nov 10 (Tue)CN¥19.72−0.19−0.95%
Nov 9 (Mon)CN¥19.91−0.18−0.90%
2026-09-22 変更届 广州白云山医药集团股份有限公司关于控股股东股权结构变更的提示性公告2026-10-10 対外投資 广州白云山医药集团股份有限公司关于股权投资基金完成管理人变更备案暨关联… / 新薬・製品の承認 广州白云山医药集团股份有限公司关于子公司收到药品注册证书的公告2026-10-13 新薬・製品の承認 广州白云山医药集团股份有限公司关于子公司获得药物临床试验批准通…2026-10-14 取締役会 H股公告(董事会召开日期)2026-10-16 新薬・製品の承認 广州白云山医药集团股份有限公司关于子公司药品通过仿制药一致性评…2026-10-27 新薬・製品の承認 广州白云山医药集团股份有限公司关于子公司药物进入II期临床试验的…2026-10-29 取締役会決議 广州白云山医药集团股份有限公司第十届董事会第五次会议决议公告 / 新薬・製品の承認 广州白云山医药集团股份有限公司关于子公司收到澳门中成药注册证明… / 第3四半期報告 广州白云山医药集团股份有限公司2026年第三季度报告2026-10-30 新薬・製品の承認 广州白云山医药集团股份有限公司关于分公司收到药品注册证书的公告2026-11-10 取締役会決議 广州白云山医药集团股份有限公司第十届董事会第六次会议决议公告2026-11-16 株主総会の招集 广州白云山医药集团股份有限公司关于召开2026年第二次临时股东会的通…2026-11-19 株主総会 广州白云山医药集团股份有限公司2026年第二次临时股东会会议资料CN¥22.66CN¥19.22May 20Nov 20
Price25-day MA75-day MASSE CompositeDisclosures
6-Month HighCN¥22.66Jul 16
6-Month LowCN¥19.22Nov 20
3-Month Change−10.6%vs Aug 20
6-Month Change−12.0%vs May 20

If you had invested CN¥10,000 6 months ago, it would be worth CN¥8,804 today (−12.0%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved −15.1%, while this stock moved −12.0%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026CN¥19.22−2.0%
Oct 2026CN¥19.61−0.6%
Sep 2026CN¥19.72−3.4%
Aug 2026CN¥20.42−8.3%
Jul 2026CN¥22.28+11.2%
Jun 2026CN¥20.04−6.9%
May 2026CN¥21.52−5.0%
2026-09-22 変更届 广州白云山医药集团股份有限公司关于控股股东股权结构变更的提示性公告2026-10-10 対外投資 广州白云山医药集团股份有限公司关于股权投资基金完成管理人变更备案暨关联… / 新薬・製品の承認 广州白云山医药集团股份有限公司关于子公司收到药品注册证书的公告2026-10-13 新薬・製品の承認 广州白云山医药集团股份有限公司关于子公司获得药物临床试验批准通…2026-10-14 取締役会 H股公告(董事会召开日期)2026-10-16 新薬・製品の承認 广州白云山医药集团股份有限公司关于子公司药品通过仿制药一致性评…2026-10-27 新薬・製品の承認 广州白云山医药集团股份有限公司关于子公司药物进入II期临床试验的…2026-10-29 取締役会決議 广州白云山医药集团股份有限公司第十届董事会第五次会议决议公告 / 新薬・製品の承認 广州白云山医药集团股份有限公司关于子公司收到澳门中成药注册证明… / 第3四半期報告 广州白云山医药集团股份有限公司2026年第三季度报告2026-10-30 新薬・製品の承認 广州白云山医药集团股份有限公司关于分公司收到药品注册证书的公告2026-11-10 取締役会決議 广州白云山医药集团股份有限公司第十届董事会第六次会议决议公告2026-11-16 株主総会の招集 广州白云山医药集团股份有限公司关于召开2026年第二次临时股东会的通…2026-11-19 株主総会 广州白云山医药集团股份有限公司2026年第二次临时股东会会议资料CN¥26.29CN¥19.22Nov 20Nov 20
Price25-day MA75-day MASSE CompositeDisclosures
52-Week HighCN¥26.29Nov 20
52-Week LowCN¥19.22Nov 20
Year to Date−25.3%vs Dec 31
From 52-Week High−26.9%Nov 20

If you had invested CN¥10,000 1 year ago, it would be worth CN¥7,311 today (−26.9%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved −10.1%, while this stock moved −26.9%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026CN¥19.22−2.0%
Oct 2026CN¥19.61−0.6%
Sep 2026CN¥19.72−3.4%
Aug 2026CN¥20.42−8.3%
Jul 2026CN¥22.28+11.2%
Jun 2026CN¥20.04−6.9%
May 2026CN¥21.52−5.0%
Apr 2026CN¥22.65−0.9%
Mar 2026CN¥22.86−9.6%
Feb 2026CN¥25.29+0.2%
Jan 2026CN¥25.25−1.9%
Dec 2025CN¥25.74−0.2%
Nov 2025CN¥25.80―
CN¥32.62CN¥19.22Nov 20, 2023Nov 20, 2026
Price13-week MA26-week MASSE Composite
3-Year HighCN¥32.62May 13, 2024
3-Year LowCN¥19.22Nov 20, 2026
Annualized Return−14.5%
Max Drawdown−41.1%

If you had invested CN¥10,000 3 years ago, it would be worth CN¥6,254 today (−37.5%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved +16.2%, while this stock moved −37.5%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)CN¥19.22−25.3%
2025CN¥25.74―
CN¥35.93CN¥19.22Nov 22, 2021Nov 20, 2026
Price13-week MA26-week MASSE Composite
5-Year HighCN¥35.93May 22, 2023
5-Year LowCN¥19.22Nov 20, 2026
Annualized Return−8.2%
Max Drawdown−46.5%

If you had invested CN¥10,000 5 years ago, it would be worth CN¥6,529 today (−34.7%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved −0.9%, while this stock moved −34.7%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)CN¥19.22−25.3%
2025CN¥25.74―
CN¥45.49CN¥4.11Mar 1, 2001Nov 20, 2026
Price1-year MA2-year MASSE Composite
All-Time HighCN¥45.49Apr 2019
All-Time LowCN¥4.11Mar 2005
Total Change+32.6%vs Mar 2001
Annualized Return+1.1%

If you had invested CN¥10,000 in Mar 2001, it would be worth CN¥13,264 today (+32.6%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved +67.3%, while this stock moved +32.6%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)CN¥19.22−25.3%
2025CN¥25.74−9.4%
2024CN¥28.42−0.6%
2023CN¥28.60−4.0%
2022CN¥29.79−12.9%
2021CN¥34.20+16.9%
2020CN¥29.25−17.9%
2019CN¥35.61−0.4%
2018CN¥35.76+11.3%
2017CN¥32.14+34.0%
2016CN¥23.98−20.8%
2015CN¥30.27+11.7%
2014CN¥27.11−2.0%
2013CN¥27.66+42.4%
2012CN¥19.42+47.8%
2011CN¥13.14−36.5%
2010CN¥20.69+82.0%
2009CN¥11.37+93.4%
2008CN¥5.88−66.5%
2007CN¥17.55+127.6%
2006CN¥7.71+23.2%
2005CN¥6.26+42.6%
2004CN¥4.39−33.6%
2003CN¥6.61−23.2%
2002CN¥8.61−26.1%
2001CN¥11.65―

Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Mar 2001). Please check the latest prices before trading.

Key features of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (600332)

Position within Traditional Chinese Medicine (66 companies)

Dividend yield3.90%No. 12 in the industry (highest first); median 2.91%
PER14.4xBelow the industry median of 22.4x (No. 8 from the lowest)
PBR0.80xBelow the industry median of 1.94x (No. 4 from the lowest)
ROE8.09%No. 25 in the industry (highest first); median 6.29%
Market capCN¥31.2 bnNo. 6 in the industry (largest first)

Ranks among A-shares in the same industry (Eastmoney's Shenwan level-2 classification, 128 industries). PER and PBR of zero or below (losses, negative equity) are excluded and ranked from the lowest. ROE is from the latest annual results; dividend yield is the past year's dividends divided by the close (as of 11/20).

Price milestones

52-week highCN¥26.042025/11/24
52-week lowCN¥19.2211/20
Current position0.0%Where the low is 0% and the high is 100% (close on 11/20: CN¥19.22)
Year to date-25.3%No. 43 of 66 in the industry (best first)
1 year-26.9%

Based on closing prices (excluding dividends).

Calculated as of 2026/11/22 18:32 JST. Updated every evening.

Recent announcements (CNINFO, in Chinese)

Show 7 more

Filings from the past 12 months (17).

Posts

This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.

No posts yet. Be the first to write something.

Write on the Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited board

You will need this to delete your post. Please keep it safe.
By posting you agree to the board rules (Japanese). You are responsible for what you write.

More Chinese stocks in English

Chinese Stock Message Board: stocks available in English

Other boards in English